Richard Lane OBE

Richard retired as a partner in BDO Stoy Hayward, Chartered Accountants, in December 2003, through ill health caused by Type 1 Diabetes. He is now a non-executive director of several growing companies. He has always been heavily involved in a range of charitable and other community activities, and is now, amongst other responsibilities, Chairman of a Hospice.

Richard has been a serious and brittle Type 1 Diabetic since 1976, treated with insulin injections and then an insulin pump. He suffered from a substantial number of hypoglycaemic reactions and comas, and from a range of complications associated with Type 1 Diabetes. Between September 2004 and January 2005, he received three Islet Cell Transplants at King’s College Hospital, in the care of a team lead by Professors Stephanie Amiel and Nigel Heaton. From this amazing research project, he became the first Type 1 Diabetic in the UK to be able to stop taking insulin.

He is a Vice-President of Diabetes UK, a member of the UK and English Advisory Councils of Diabetes UK, and of their Finance Subcommittee.